He doesn't understand nor respect proper assessment, standards and review. That's what worries me about this maverick.
I might agree with some of his conclusions, but he's an unreliable opinion and that's the problem.
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
1.78%
!
$1.79

He doesn't understand nor respect proper assessment, standards...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.79 |
Change
-0.033(1.78%) |
Mkt cap ! $2.293B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $10.57M | 5.927M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 38812 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 54138 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 30209 | 1.795 |
11 | 45559 | 1.790 |
8 | 52605 | 1.785 |
8 | 215631 | 1.780 |
8 | 98384 | 1.775 |
Price($) | Vol. | No. |
---|---|---|
1.800 | 7691 | 17 |
1.805 | 34391 | 24 |
1.810 | 56169 | 8 |
1.815 | 80470 | 8 |
1.820 | 113598 | 10 |
Last trade - 15.35pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online